Our Mission and Values
Board
Leadership Team
Scientific Advisory
Corporate Governance
Intellectual Property
Pipeline
CVac™
Monoclonal Antibody
Vaccines Program
R&D
Ovarian Cancer
About CVac™
Treatment
Clinical Trials
Clinical Trials
CVac™
CAN-003
CANVAS
FAQ
Useful Links
Contact Us
Analyst Reports
Presentations
Annual Reports
Mailing List
Movie about CVac™
Investor Updates
Announcements
Announcements
Archive
Announcements
06/03/2010
European Orphan Drug Designation
Article as pdf
>>
Privacy Policy
© 2012 PRIMA BIOMED LTD. All Rights Reserved.
Print
Home
Site Map
Contact Us
Search